Will Pharma Finally Score a Policy Win for 340B?

Will pharma finally score a policy win for 340B?

The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight.

AHA report: Hospitals are complying with 340B rules, but drug companies are not

The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater oversight by the federal government, but they also significantly outperform drug companies in terms of program compliance.  The report analyzed publicly available federal audit data and observed trends in findings for both 340B hospitals and drug companies from fiscal years 2018-2022. Duplicate…

Senator Cassidy Report Reveals Billions Flowing Through CVS and Walgreens Specialty Pharmacies in 340B Program

Senator Bill Cassidy, chair of the Senate Committee on […] The post Senator Cassidy Report Reveals Billions Flowing Through CVS and Walgreens Specialty Pharmacies in 340B Program first appeared on GeneOnline News. The post Senator Cassidy Report Reveals Billions Flowing Through CVS and Walgreens Specialty Pharmacies in 340B Program appeared first on GeneOnline News.